New Delhi, May 31 (IANS) The US Food and Drug Administration (FDA) has flagged serious manufacturing, maintenance and data integrity lapses at a Dabur India manufacturing facility in Dadra and Nagar Haveli, at a time when Indian pharmaceutical and healthcare product makers are facing increased scrutiny from US regulators over quality standards and manufacturing practices.According to the FDA inspection report, the regulator identified multiple deficiencies at the plant, raising concerns over pot…
Trending
- Trendy Tunics for Summer – Breezy Tunic Tops Styled for the Heat
- Dark Movie Review: Ajay Karthi’s Atmospheric Horror-Thriller Delivers Genuine Chills
- Super Subbu Review: Sundeep Kishan’s Bold Netflix Series Blends Humour, Heart, and a Powerful Message
- Nevermind 2026 Movie Review: Rituparna Sengupta Anchors a Hauntingly Atmospheric Bengali Mystery-Drama
- Rao Bahadur Movie Review: Satyadev Delivers a Career-Defining Performance in This Bold Psychological Drama
- Graamaayana Movie Review: Vinay Rajkumar’s Heartfelt Rural Drama Wins Hearts
- Alpha Movie Review: Alia Bhatt and Sharvari Redefine Action Cinema in YRF’s Boldest Spy Universe Chapter Yet
- Nagabandham: The Secret Treasure Movie Review — A Grand Mythological Adventure Worth Experiencing